Novel Paradigm for Developing Highly Efficient Contrast Agent

FDA-approved iron oxide nanocrystals (IONs) as negative magnetic resonance imaging (MRI) contrast agents are experiencing obstacles due to their low relaxation rate and coherent ferromagnetism. Though metal doping has been discovered to be an effective method of improving the magnetic property and MRI contrast performance, the systemic mechanism has rarely been discussed.